NY State Senate Bill 2017-S2193

Senate Bill S2193

2017-2018 Legislative Session

Authorizes and directs the department of health to conduct a study on drugs prescribed for school age children with ADD and ADHD

download bill text pdf

Archive: Last Bill Status - In Senate Committee Health Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 03, 2018	referred to health
Jan 12, 2017	referred to health

2017-S2193 (ACTIVE) - Details

See Assembly Version of this Bill:: A6390
Current Committee:: Senate Health
Law Section:: Health, Commissioner of
Versions Introduced in Other Legislative Sessions:: 2009-2010: S8202
2011-2012: S1172
2013-2014: S3100
2015-2016: S2761, A6785
2019-2020: S2599, A3439
2021-2022: S3167, A4527
2023-2024: S4677, A1969

2017-S2193 (ACTIVE) - Summary

Authorizes and directs the department of health to conduct a study on drugs prescribed for school-age children with ADD and ADHD.

2017-S2193 (ACTIVE) - Sponsor Memo

                                 BILL NUMBER:  S2193

 TITLE OF BILL :

An act authorizing and directing the department of health to do
research and study as to the effects of psychostimulants, selective
seratonin reuptake inhibitors, antidepressants and other drugs which
are prescribed for attention deficit disorders, ADD and ADHD, for
school age children

 PURPOSE OR GENERAL IDEA OF THE BILL :

To conduct a study on drugs prescribed for school-age children with
ADD and ADHD, making recommendations thereafter.

 SUMMARY OF SPECIFIC PROVISIONS :

Authorizes the commissioner of health, in conjunction with the
commissioner of mental health, the commissioner of mental retardation
and developmental disabilities, and the commissioner of education
to.conduct a study and do research as to the effect of psycho
stimulants, selective serotonin reuptake inhibitors, antidepressants
and other drugs prescribed for ADD and ADHD, in school age children.
The commissioner shall report his or her findings to the governor, the
sneaker of the assembly and the temporary president of the senate
within two years that this act shall take effect.

 JUSTIFICATION :

Currently 5 million school kids in America are on psychotropic drugs
that are prescribed and administered by their schools. (Insight
Magazine, June 1996). Kids are routinely being misdiagnosed and forced
to take drugs for behavior problems, often containing violent side
effects. This problem is becoming an epidemic with no end in sight. It
is imperative that the commissioner of health performs a study on the
effect of medicating our school children, and making recommendations
thereafter.

 PRIOR LEGISLATIVE HISTORY :

2015-16: S.2761 - Referred to Health
2013-14: S.3100 - Referred to Health
2011-12: S.1172 - Referred to Health
2009-10: S.8202/A.5602 - Passed Both Houses, Vetoed Memo 6752
2008-09: A.5388 - Passed Assembly
2007-08: A.5388 - Passed Assembly
2006-07: A.5885A - Passed Assembly
2005-06: A.5885 - Health

 EFFECTIVE DATE :
This act shall take effect immediately; provided, however, that if
chapter 97 of the laws of 2016 shall not have taken effect on or
before such date then section one of this act shall take effect on the
same date and in the same manner as such chapter of the laws of 2016.

2017-S2193 (ACTIVE) - Bill Text download pdf

                            
 
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   2193
 
                        2017-2018 Regular Sessions
 
                             I N  S E N A T E
 
                             January 12, 2017
                                ___________
 
 Introduced  by  Sen.  PARKER -- read twice and ordered printed, and when
   printed to be committed to the Committee on Health
 
 AN ACT authorizing and directing the department of health to do research
   and study as to the effects of psychostimulants,  selective  seratonin
   reuptake   inhibitors,  antidepressants  and  other  drugs  which  are
   prescribed for attention deficit disorders, ADD and ADHD,  for  school
   age children
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. 1.  The commissioner of health,  in  conjunction  with  the
 commissioner  of  mental health, the commissioner of developmental disa-
 bilities, and the commissioner of education is authorized  and  directed
 to conduct a study and do research as to the effect of psychostimulants,
 selective serotonin reuptake inhibitors, antidepressants and other drugs
 prescribed for attention deficit disorder, attention deficit hyperactiv-
 ity  disorder, and the increasing rate of diagnosis of these conditions,
 in school age children.
   2. The study shall be conducted in accordance with rules,  regulations
 and  standards  determined  by the commissioner of health, and the study
 shall concentrate on harmful side effects of such drugs,  the  appropri-
 ateness  and effectiveness of tools and methods used to assess and diag-
 nose the condition, the appropriateness of  different  medications,  and
 any demographic disparities in diagnosis.
   3.  The commissioner of health shall report his or her findings to the
 governor, the speaker of the assembly and the temporary president of the
 senate on or before two years from the date this act shall take effect.
   § 2. This act shall take effect immediately.
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD06179-01-7

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.